Pantoprazole

Product overview

Pantoprazole pellets from Rraynex underpin a broad portfolio of proton pump inhibitor therapies that call for multiple strengths. Manufacturing starts with pharmacopeial pantoprazole sodium sesquihydrate processed in humidity-controlled suites. Seal coats, drug layering, and enteric polymers are carefully sequenced to protect the acid-labile core while delivering low ash content for downstream compression. Pellets exhibit consistent size distribution, supporting MUPS tablets, capsules, or sachet formulations without segregation. Quality monitoring covers assay, moisture, and dissolution across strengths to maintain predictable gastric resistance. We supply detailed technical information encompassing dissolution comparisons, impurity trend analyses, and stability data aligned to ICH zones. Packaging is flexible, with moisture-barrier drums, foil-lined bags, and pilot-scale packs available to match forecast demand. Technical teams assist with method transfers, lubricant selection, and compatibility evaluations with excipients such as MCC, crospovidone, or mannitol. Regulatory specialists maintain ready-to-file CTD modules and transparent change-control logs, allowing customers to launch or scale pantoprazole products efficiently.